Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GLIMEPIRIDE for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 17 adverse event reports in the FDA FAERS database where GLIMEPIRIDE was used for Psoriasis.

Most Reported Side Effects for GLIMEPIRIDE

Side Effect Reports % Deaths Hosp.
Hypoglycaemia 1,403 25.2% 71 967
Blood glucose increased 446 8.0% 6 102
Acute kidney injury 339 6.1% 46 220
Drug ineffective 339 6.1% 1 60
Diarrhoea 257 4.6% 44 115
Blood glucose decreased 232 4.2% 8 68
Lactic acidosis 219 3.9% 40 130
Glycosylated haemoglobin increased 214 3.8% 1 55
Diabetes mellitus inadequate control 213 3.8% 2 46
Hypoglycaemic coma 187 3.4% 15 123
Toxicity to various agents 185 3.3% 71 139
Nausea 180 3.2% 38 99
Vomiting 178 3.2% 5 128
Fall 150 2.7% 6 123
Completed suicide 146 2.6% 146 49

Other Indications for GLIMEPIRIDE

Type 2 diabetes mellitus (1,681) Diabetes mellitus (1,298) Product used for unknown indication (1,267) Hyperglycaemia (43) Blood glucose increased (37) Suicide attempt (29) Blood glucose abnormal (19) Type 1 diabetes mellitus (14) Blood glucose decreased (12) Accidental exposure to product (10)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

GLIMEPIRIDE Full Profile All Psoriasis Drugs GLIMEPIRIDE Demographics GLIMEPIRIDE Timeline